PTEN公司
雷达51
磷酸化
癌症研究
胶质瘤
放射治疗
辐射灵敏度
DNA损伤
DNA修复
电离辐射
酪氨酸磷酸化
生物
PI3K/AKT/mTOR通路
细胞生物学
DNA
医学
信号转导
内科学
生物化学
物理
辐照
核物理学
作者
Jianhui Ma,Jorge A. Benítez,Jie Li,Shunichiro Miki,Claudio P. Albuquerque,Thais Fernanda de Almeida Galatro,Laura Orellana,Ciro Zanca,Rachel Reed,Antonia Boyer,Tomoyuki Koga,Nissi Varki,Tim R. Fenton,Suely Kazue Nagahashi Marie,Erik Lindahl,Timothy C. Gahman,Andrew K. Shiau,Huilin Zhou,John DeGroot,Erik P. Sulman
出处
期刊:Cancer Cell
[Cell Press]
日期:2019-02-28
卷期号:35 (3): 504-518.e7
被引量:134
标识
DOI:10.1016/j.ccell.2019.01.020
摘要
Ionizing radiation (IR) and chemotherapy are standard-of-care treatments for glioblastoma (GBM) patients and both result in DNA damage, however, the clinical efficacy is limited due to therapeutic resistance. We identified a mechanism of such resistance mediated by phosphorylation of PTEN on tyrosine 240 (pY240-PTEN) by FGFR2. pY240-PTEN is rapidly elevated and bound to chromatin through interaction with Ki-67 in response to IR treatment and facilitates the recruitment of RAD51 to promote DNA repair. Blocking Y240 phosphorylation confers radiation sensitivity to tumors and extends survival in GBM preclinical models. Y240F-Pten knockin mice showed radiation sensitivity. These results suggest that FGFR-mediated pY240-PTEN is a key mechanism of radiation resistance and is an actionable target for improving radiotherapy efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI